این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
دوشنبه 24 آذر 1404
مجله علوم اعصاب شفای خاتم
، جلد ۵، شماره ۲، صفحات ۱۳۶-۱۳۶
عنوان فارسی
P ۱۰۵: The Role of LRRK۲ Inhibitors in Treatment of Parkinson’s Disease
چکیده فارسی مقاله
لطفاً به چکیده انگلیسی مراجعه شود.
کلیدواژههای فارسی مقاله
عنوان انگلیسی
P 105: The Role of LRRK2 Inhibitors in Treatment of Parkinson’s Disease
چکیده انگلیسی مقاله
Parkinson's disease is the second most common age associated neuron degenerative disorder in developed societies. With the prevalence ranging from 41 per 100000 in the fourth decade of life to over 1900 per 100000 in people over 80 years of age.it characterized clinically by resting tremor, slowness of movement, rigidity and postural instability in the result of progressive loss of dopaminergic neurons in the substantia nigra. Although a variety of possible pathogenic mechanisms have been proposed over the years its etiology has not yet been fully understood. Chronic inflammation is one of the etiologies of Parkinson's disease and play vital role in the degeneration of dopaminergic neurons. Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are found in Parkinson's disease, as in immune related disorder including Crohn's disease and leprosy. Increasing evidence suggests that LRRK2 protein play an important role in innate immunity. A process that occurs in neurodegenerative disease including Parkinson's disease.LRRK2 is a large and complex protein with a unique multiple domain architecture and that can function as a protein kinase with many putative substrates identified and can also function as a GTPase that may serve in part to regulate kinase activity. The combined genetic and biochemical evidence supports a hypothesis in which the LRRK2 kinase function is involved in the pathogenesis of sporadic and familial form of Parkinson's disease. This finding suggests that LRRK2 kinase inhibitors may potentially offer new treatment for Parkinson's disease.
کلیدواژههای انگلیسی مقاله
Neuroinflammation, Parkinson’s disease, LRRK2 inhibitors
نویسندگان مقاله
مریم ایران نژاد | maryam irannejad
islamic azad university, mashhad branch, mashhad, iran
سازمان اصلی تایید شده
: دانشگاه آزاد اسلامی علوم و تحقیقات (Islamic azad university science and research branch)
مهدیه عباسی | mahdie abbasi
islamic azad university, mashhad branch, mashhad, iran
سازمان اصلی تایید شده
: دانشگاه آزاد اسلامی علوم و تحقیقات (Islamic azad university science and research branch)
نشانی اینترنتی
http://shefayekhatam.ir/browse.php?a_code=A-10-24-955&slc_lang=en&sid=fa
فایل مقاله
اشکال در دسترسی به فایل - ./files/site1/rds_journals/337/article-337-393409.pdf
کد مقاله (doi)
زبان مقاله منتشر شده
fa
موضوعات مقاله منتشر شده
تحقیقات پایه در علوم اعصاب
نوع مقاله منتشر شده
مروری
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات